Literature DB >> 21787758

Linear ubiquitination in NF-κB signaling and inflammation: What we do understand and what we do not.

Kelly Verhelst1, Lynn Verstrepen, Isabelle Carpentier, Rudi Beyaert.   

Abstract

Despite its small size, ubiquitin is one of the most versatile signaling molecules in the cell and affects distinct cellular processes. It forms the building block of a repertoire of posttranslational modifications of cellular proteins, ranging from the attachment of a single ubiquitin to ubiquitin chains of different linkage. Proteins that contain ubiquitin chain-specific ubiquitin-binding domains recognize different types of ubiquitination and determine the mode of signaling of modified proteins. Polyubiquitin chains were thought to be formed only by the conjugation of the ubiquitin C-terminal Gly to one of the seven internal Lys residues of another ubiquitin. However, the C-terminal Gly was recently shown to also link to the N-terminus of another ubiquitin to form head-to-tail polyubiquitin chains, which is referred to as linear ubiquitination. These linear linkages can be assembled and conjugated to another protein by an E3 ligase complex known as LUBAC, and are recognized by a particular ubiquitin-binding domain known as UBAN. Both have been implicated in the regulation of TNF-induced NF-κB signaling, which induces the expression of a wide range of proteins that mediate many biological processes including inflammation and cell survival. We discuss the molecular players and mechanisms that determine the specificity and outcome of linear ubiquitination in NF-κB signaling, as well as future directions and challenges ahead.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21787758     DOI: 10.1016/j.bcp.2011.07.066

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

Review 1.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

2.  A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7.

Authors:  Kelly Verhelst; Isabelle Carpentier; Marja Kreike; Laura Meloni; Lynn Verstrepen; Tobias Kensche; Ivan Dikic; Rudi Beyaert
Journal:  EMBO J       Date:  2012-08-28       Impact factor: 11.598

3.  Fluorescence-based sensors to monitor localization and functions of linear and K63-linked ubiquitin chains in cells.

Authors:  Sjoerd J L van Wijk; Evgenij Fiskin; Mateusz Putyrski; Francesco Pampaloni; Jian Hou; Philipp Wild; Tobias Kensche; Hernan E Grecco; Philippe Bastiaens; Ivan Dikic
Journal:  Mol Cell       Date:  2012-07-19       Impact factor: 17.970

Review 4.  Emerging role of ubiquitination in antiviral RIG-I signaling.

Authors:  Jonathan Maelfait; Rudi Beyaert
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

5.  Structure and recognition of polyubiquitin chains of different lengths and linkage.

Authors:  David Fushman; Keith D Wilkinson
Journal:  F1000 Biol Rep       Date:  2011-12-01

Review 6.  Nuclear Factor-kappaB in Autoimmunity: Man and Mouse.

Authors:  Bahar Miraghazadeh; Matthew C Cook
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

7.  Investigating Common Pathogenic Mechanisms between Homo sapiens and Different Strains of Candida albicans for Drug Design: Systems Biology Approach via Two-Sided NGS Data Identification.

Authors:  Shan-Ju Yeh; Chun-Chieh Yeh; Chung-Yu Lan; Bor-Sen Chen
Journal:  Toxins (Basel)       Date:  2019-02-15       Impact factor: 4.546

8.  HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination.

Authors:  T Li; J Guan; S Li; X Zhang; X Zheng
Journal:  Cell Death Dis       Date:  2014-05-15       Impact factor: 8.469

9.  Expression of the three components of linear ubiquitin assembly complex in breast cancer.

Authors:  Amirhossein Kharman-Biz; Hui Gao; Reza Ghiasvand; Lars-Arne Haldosen; Kazem Zendehdel
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.